Founded in 2017, Axil Capital was spun out of Mizuho Securities and focuses on investing in early-stage companies in the biomedical and healthcare technology sectors. The firm's investment strategy is to provide capital and support to companies with innovative technologies that have the potential to revolutionize the healthcare industry. Axil Capital's team of experienced investors and industry experts work closely with portfolio companies to help them achieve their goals and bring their products to market.